Activation of mTOR: a culprit of Alzheimer’s disease?

Código QR

Activation of mTOR: a culprit of Alzheimer’s disease?

Zhiyou Cai,1 Guanghui Chen,1 Wenbo He,1 Ming Xiao,2 Liang-Jun Yan31Department of Neurology, Renmin Hospital, Hubei University of Medicine, Shiyan Renmin Hospital, Shiyan, Hubei Province, People’s Republic of China; 2Department of Anatomy, Nanjing Medical University, Nanjing, Jiangsu, Peop...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cai Z, Chen G, He W, Xiao M, Yan LJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/ec4a8021a322446b9a23fb17eb23e857
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Neuroinflammation in Alzheimer’s disease
por: Zhang FJ, et al.
Publicado: (2015)

Magnetic resonance spectroscopy in Alzheimer’s disease
por: Graff-Radford J, et al.
Publicado: (2013)

Update on the use of memantine in Alzheimer&rsquo;s disease
por: Robert J van Marum
Publicado: (2009)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
por: Koppel J, et al.
Publicado: (2014)

Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative
por: Samtani MN, et al.
Publicado: (2014)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
por: J&uuml;rgen G&ouml;tz, et al.
Publicado: (2008)

Intrathecal corticosteroids might slow Alzheimer&rsquo;s disease progression
por: Joseph Martin Alisky
Publicado: (2008)

Caregiver burden and coping strategies in caregivers of patients with Alzheimer’s disease
por: Iavarone A, et al.
Publicado: (2014)

Present and prospective clinical therapeutic regimens for Alzheimer&rsquo;s disease
por: Mustafa M Husain, et al.
Publicado: (2008)

The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
por: Tousi B
Publicado: (2015)

Serum homocysteine levels are correlated with behavioral and psychological symptoms of Alzheimer’s disease
por: Kim H, et al.
Publicado: (2014)

Cognitive impairment and Alzheimer’s disease: Links with oxidative stress and cholesterol metabolism
por: Alejandra Sekler, et al.
Publicado: (2008)

Role of berberine in Alzheimer’s disease
por: Cai Z, et al.
Publicado: (2016)

Brain amyloid &beta; protein and memory disruption in Alzheimer&rsquo;s disease
por: Weiming Xia
Publicado: (2010)

Optimal management of Alzheimer&rsquo;s disease patients: Clinical guidelines and family advice
por: Julia Haberstroh, et al.
Publicado: (2010)

Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT
por: Aksay SS, et al.
Publicado: (2014)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice
por: Seibert J, et al.
Publicado: (2012)

Could lysine supplementation prevent Alzheimer&rsquo;s dementia? A novel hypothesis
por: Robert N Rubey
Publicado: (2010)

Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer’s disease
por: Pereira ML, et al.
Publicado: (2014)

An exploratory study of the association between SORL1 polymorphisms and sporadic Alzheimer’s disease in the Han Chinese population
por: Zhang F, et al.
Publicado: (2015)

Apraxia for differentiating Alzheimer’s disease from subcortical vascular dementia and mild cognitive impairment
por: Ozkan S, et al.
Publicado: (2013)

Association of EEG, MRI, and regional blood flow biomarkers is predictive of prodromal Alzheimer’s disease
por: Moretti DV
Publicado: (2015)

Reproductive life events and Alzheimer&rsquo;s disease in Italian women: a retrospective study
por: Bono G, et al.
Publicado: (2012)

Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer&rsquo;s disease
por: William J McGeown, et al.
Publicado: (2008)

Adjunct effect of music therapy on cognition in Alzheimer’s disease in Taiwan: a pilot study
por: Li CH, et al.
Publicado: (2015)

Galantamine versus donepezil in Chinese patients with Alzheimer&rsquo;s disease: results from a randomized, double-blind study
por: Zhang Z, et al.
Publicado: (2012)

Mechanism of Autophagy Regulation in MPTP-Induced PD Mice via the mTOR Signaling Pathway by Echinacoside
por: Zhang ZN, et al.
Publicado: (2021)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer&rsquo;s disease
por: Umamon Puangthong, et al.
Publicado: (2009)

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
por: Hager K, et al.
Publicado: (2014)

Estrogen receptor-mediated neuroprotection: The role of the Alzheimer&rsquo;s disease-related gene seladin-1
por: Alessandro Peri, et al.
Publicado: (2008)

A review of the potential therapeutic role of statins in the treatment of Alzheimer&rsquo;s disease: current research and opinion
por: Mitchell AJ, et al.
Publicado: (2013)

Functional imaging of hippocampal dysfunction among persons with Alzheimer&rsquo;s disease: a proof-of-concept study
por: David B Arciniegas, et al.
Publicado: (2010)

Voxel-Based Morphometry Analysis of Structural MRI for Differentiation Between Dementia with Lewy Bodies and Alzheimer’s Disease [Letter]
por: Inui S, et al.
Publicado: (2020)

Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer&rsquo;s disease: a voxel-based morphometry study
por: Nakaaki S, et al.
Publicado: (2012)

Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer’s Disease Neuroimaging Initiative)
por: Harris P, et al.
Publicado: (2015)

Brain ischemia and ischemic blood&ndash;brain barrier as etiological factors in sporadic Alzheimer&rsquo;s disease
por: Ryszard Pluta, et al.
Publicado: (2008)

The efficacy of mirtazapine in agitated patients with Alzheimer&rsquo;s disease: A 12-week open-label pilot study
por: Sibel Cakir, et al.
Publicado: (2008)

Diagnostic performance of a combination of Mini-Mental State Examination and Clock Drawing Test in detecting Alzheimer’s disease
por: Kato Y, et al.
Publicado: (2013)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer&rsquo;s disease receiving donepezil
por: Kano O, et al.
Publicado: (2013)